Blog

The transition from discovery research to clinical development represents a critical pivot point in drug manufacturing. To successfully advance a candidate, developers must execute a series of robust, comprehensive IND-enabling studies that satisfy regulatory…

The transition from research to clinical development represents a critical point in drug development. The IND (Investigational New Drug) application is often mischaracterized as a milestone to be cleared, but U.S FDA views it as a tool to protect patients and a legal…

Transitioning to the first IND clinical trial is fraught with many operational and scientific risks. While the regulatory submission process focuses on safety and justification, the execution phase shifts the burden toward meticulous laboratory performance. Often, a…

The transition from preclinical research to clinical investigation remains one of the most demanding phases in pharmaceutical development. While IND submission is often viewed as the finish line for early-stage development, regulatory authorities characterize it as…

One of the defining challenges in oligonucleotide therapeutics has not been ensuring their ability to modulate genes, but rather how to deliver their effects precisely where they are needed. Following the success of GalNAc conjugates in liver targeting, the field has…

Oncolytic viruses have emerged as a promising class of cancer therapeutics that combine direct tumor destruction with immune system activation. Unlike traditional oncology treatments, these engineered viruses are designed to selectively infect and replicate within…

Alzheimer’s disease (AD) is increasingly understood not only as a clinical syndrome, but as a biological disease process that begins years before memory loss or other cognitive symptoms become apparent. Because amyloid beta (Aβ) deposition, tau pathology,…

In the early stages of drug research, the ability to predict how a human body will process a chemical is essential for preventing failure in late-stage trials. This predictive ability is primarily driven by in vitro ADME testing, a suite of assays designed to evaluate…

Metabolite identification studies play a central role in modern drug development because they help drug developers understand how a compound is transformed within biological systems and whether resulting metabolites may create additional safety, exposure, or…

A PK study is one of the earliest opportunities in preclinical development to understand how a drug behaves within a biological system, including how it is absorbed, distributed, metabolized, and eliminated over time. While PK studies are often viewed as routine…

Whole Slide Images (WSIs), also known as digital or virtual slides, are digitized images generated from traditional glass slides using specialized hardware and software. WSIs have been widely used as an alternative to glass slides across various clinical diagnostic…

Obesity and type 2 diabetes remain major global health burdens, with WHO estimating that roughly 890 million people were living with obesity in 2022 and 2.5 billion adults were overweight. GLP-1 therapies have already changed treatment expectations, but the larger…